Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality

Pierre Fillatre, Marie-José Dufour, Sylvie Behillil, Remi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy, Edith Droumaguet, Véronique Merour, Vincent Enouf, Rodolphe Buzele, Marion Valence, Elena Guillotel, Bertrand Gagniere, Artem Baidaluk, Anna Zhukova, Mathieu Tourdjman, Vincent Thibault, Claire Grolhier, Charlotte Pronier, Xavier Lescure, View ORCID ProfileEtienne Simon-Loriere, Dominique Costagliola, Sylvie Van Der Werf, Pierre Tattevin, Nicolas Massart
doi: https://doi.org/10.1101/2021.05.05.21256690
Pierre Fillatre
1Service de Réanimation polyvalente, CH de Saint-Brieuc, 10, rue Marcel Proust 22000 Saint-Brieuc, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-José Dufour
2Service de Biologie médicale, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Behillil
3National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, CNRS-UMR 3569, University of Paris, Institut Pasteur, Paris, France
P.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remi Vatan
4Service de Médecine Interne, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
5Service de Maladies Infectieuses, CH de Saint-Brieuc, 10 rue Marcel Proust 22000 Saint-Brieuc, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascale Reusse
6Service de Gériatrie, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice Gabellec
6Service de Gériatrie, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Velmans
4Service de Médecine Interne, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Montagne
7Service d’Imagerie Médicale, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Geffroy
8Service de Pneumologie, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edith Droumaguet
9Département d’informatique médicale, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Merour
10Plateforme de surveillance continue, CH de Lannion, Centre Hospitalier Pierre-le-Damany, 22303 Lannion, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Enouf
3National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, CNRS-UMR 3569, University of Paris, Institut Pasteur, Paris, France
11Mutualized Platform of Microbiology, Pasteur International Bioresources Network, Institut Pasteur, Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodolphe Buzele
5Service de Maladies Infectieuses, CH de Saint-Brieuc, 10 rue Marcel Proust 22000 Saint-Brieuc, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion Valence
5Service de Maladies Infectieuses, CH de Saint-Brieuc, 10 rue Marcel Proust 22000 Saint-Brieuc, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Guillotel
12Service de Biologie médicale, CH de Saint-Brieuc, 10, rue Marcel Proust 22000 Saint-Brieuc, France
M.D
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Gagniere
13Santé publique France, French national public health agency, Cellule Bretagne, Rennes, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Artem Baidaluk
14Evolutionary Genomics of RNA Viruses, Institut Pasteur, Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Zhukova
15Unité Bioinformatique Evolutive & Hub de Bioinformatique et Biostatistique - Département Biologie computationnelle, USR3756 (C3BI/DBC), Institut Pasteur, Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Tourdjman
16Santé publique France, the French public health agency, Saint-Maurice, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Thibault
17Service de Virologie, CHU de Rennes, 2, rue Henri le Guilloux 35000 Rennes, France
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Grolhier
17Service de Virologie, CHU de Rennes, 2, rue Henri le Guilloux 35000 Rennes, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Pronier
17Service de Virologie, CHU de Rennes, 2, rue Henri le Guilloux 35000 Rennes, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Lescure
18Department of Infectious and Tropical Diseases, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France; Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etienne Simon-Loriere
14Evolutionary Genomics of RNA Viruses, Institut Pasteur, Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Etienne Simon-Loriere
Dominique Costagliola
19Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique (IPLESP), Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Van Der Werf
3National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, CNRS-UMR 3569, University of Paris, Institut Pasteur, Paris, France
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Tattevin
20Service de maladie infectieuse et de réanimation médicale, CHU de Rennes, 2, rue Henri le Guilloux 35000 Rennes, France
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pierre.fillatre{at}armorsante.bzh
Nicolas Massart
1Service de Réanimation polyvalente, CH de Saint-Brieuc, 10, rue Marcel Proust 22000 Saint-Brieuc, France
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background In early January 2021, an outbreak of nosocomial cases of COVID-19 emerged in Western France, with RT-PCR tests repeatedly negative on nasopharyngeal samples but positive on lower respiratory tract samples. Whole genome sequencing (WGS) revealed a new variant, currently defining a novel SARS-CoV-2 lineage: B.1.616. In March, WHO classified this variant as ‘under investigation’ (VUI). We analyzed the characteristics and outcomes of COVID-19 cases related to this new variant.

Methods Clinical, virological, and radiological data were retrospectively collected from medical charts in the two hospitals involved. We enrolled patients with at least one of the following: i) positive SARS-CoV-2 RT-PCR on a respiratory sample; ii) seroconversion with anti-SARS-CoV-2 IgG/IgM; iii) suggestive symptoms and typical features of COVID-19 on chest CT scan. Cases were categorized as either: i) B.1.616; ii) variant of concern (VOC); iii) unknown.

Findings From January 1st to March 24th, 2021, 114 patients fulfilled the inclusion criteria: B.1.616 (n=34), VOC (n=32), and unknown (n=48). B.1.616-related cases were older than VOC-related cases (81 years [73-88], vs 73 years [67-82], P<0.05) and their first RT-PCR tests were less often positive (5/34, 15% vs 31/32, 97%, P<0.05). The B.1.616 variant was independently associated with severe disease (multivariable Cox model HR 4.2 [1.3– 13.5], P=0.018), and increased lethality (logrank test P=0.01): 28-day mortality 15/34 (44%) with B.1.616, vs. 5/32 (16%) for VOC, P=0.036.

Interpretation We report a nosocomial outbreak of COVID-19 cases related to a new variant, B.1.616, poorly detected by RT-PCR on nasopharyngeal samples, with high lethality.

Evidence before this study Among the numerous SARS-CoV-2 variants described worldwide, only 3 are currently classified as Variant of Concern (VOC) by the WHO, since they are associated with either an increased risk in transmissibility, severity, or significant reduction in neutralization by antibodies: B.1.1.7, B.1.351 and P.1 (Pango lineage nomenclature). With the ongoing circulation of SARS-CoV-2 in many places worldwide, the emergence of new variants may reduce the efficacy of vaccines and jeopardize our prospects to control the pandemic. In early January 2021, an outbreak of cases highly suggestive of COVID-19 despite negative RT-PCR tests on repeated nasopharyngeal (NP) samples was reported in Western France, leading to several nosocomial clusters. Whole-genome sequencing (WGS) from lower respiratory tract samples identified a new lineage of SARS-CoV-2 virus, classified as B1.616. Consequently, the French public health agency (Santé publique France) and the WHO classified B.1.616 as ‘variant under investigation’ (VUI).

Added value of this study Our observational study, conducted from January 1st to March 24th 2021 in the B.1.616 identified area, provides the first clinical and virological description of B.1.616-associated COVID-19. The 34 cases had clinical, biological and radiological findings in line with classical features of COVID-19, while RT-PCR tests on nasopharyngeal (NP) samples failed to detect SARS-CoV-2 in most patients. Indeed, this gold-standard test was positive in only 15% of the first tests in B.1.616-related COVID-19 patients. Of note, the diagnostic performance of RT-PCR tests was satisfactory on lower respiratory tract samples, suggesting that failure to detect B.1.616 on NP samples would be due to a viral load below the limit of detection in the upper respiratory tract, rather than to genomic mismatches between routine RT-PCR targets and this variant. In our cohort, B.1.616 was independently associated with worse clinical outcome, with high 28-day mortality (44%).

Implications of all the available evidence Diagnosis of B.1.616-related COVID-19 cases should not rely on RT-PCR tests on NP samples. In the epidemic area, strict infection control measures must be maintained as long as COVID-19 diagnosis is not ruled out, in order to limit nosocomial clusters and case fatality. Further studies are needed to confirm and investigate the association between genomic characteristics of B.1.616, and i) poor detection by RT-PCR tests on NP samples; ii) prognosis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The French infectious diseases society ethics committee (Comite d Ethique de la Recherche en Maladies Infectieuses et Tropicales, CER-MIT) approved the study (N COVID 2021-06).

Institutional Review Board N IRB00011642

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

A complete de-identified patient dataset, accompanied by the original study protocol will be available to European researchers on request. Individuals wishing to access the data should send a request to pierre.fillatre{at}armorsante.bzh.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
Pierre Fillatre, Marie-José Dufour, Sylvie Behillil, Remi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy, Edith Droumaguet, Véronique Merour, Vincent Enouf, Rodolphe Buzele, Marion Valence, Elena Guillotel, Bertrand Gagniere, Artem Baidaluk, Anna Zhukova, Mathieu Tourdjman, Vincent Thibault, Claire Grolhier, Charlotte Pronier, Xavier Lescure, Etienne Simon-Loriere, Dominique Costagliola, Sylvie Van Der Werf, Pierre Tattevin, Nicolas Massart
medRxiv 2021.05.05.21256690; doi: https://doi.org/10.1101/2021.05.05.21256690
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality
Pierre Fillatre, Marie-José Dufour, Sylvie Behillil, Remi Vatan, Pascale Reusse, Alice Gabellec, Nicolas Velmans, Catherine Montagne, Sophie Geffroy, Edith Droumaguet, Véronique Merour, Vincent Enouf, Rodolphe Buzele, Marion Valence, Elena Guillotel, Bertrand Gagniere, Artem Baidaluk, Anna Zhukova, Mathieu Tourdjman, Vincent Thibault, Claire Grolhier, Charlotte Pronier, Xavier Lescure, Etienne Simon-Loriere, Dominique Costagliola, Sylvie Van Der Werf, Pierre Tattevin, Nicolas Massart
medRxiv 2021.05.05.21256690; doi: https://doi.org/10.1101/2021.05.05.21256690

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13378)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1141)
  • Health Systems and Quality Improvement (1191)
  • Hematology (431)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4927)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (725)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4214)
  • Public and Global Health (7506)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)